Stock Events

Stock Events

BVZ 

€1,620
0
+€30+1.89% Wednesday 06:30

Statistics

Day High
1,610
Day Low
1,610
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.04%
Dividend
33.11

Upcoming

14
APR
Dividend Ex
Increased
 
16
APR
Dividend Payment
Increased
 
14
APR 27
Dividend Ex
Estimated
 
16
APR 27
Dividend Payment
Estimated
 
14
APR 28
Dividend Ex
Estimated
 
14
APR 28
Dividend Payment
Estimated
 

Dividends

2.04%Dividend Yield
Apr 26
€33.11
Apr 25
€19.43
Apr 24
€16.47
Apr 23
€15.29
Apr 22
€2.92
10Y Growth
12.67%
5Y Growth
N/A
3Y Growth
29.54%
1Y Growth
71.13%

Financials

15.88%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
288.15MRevenue
45.75MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5K5.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company based in Switzerland, directly competing with BVZ in various pharmaceutical and biotech segments.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is another Swiss multinational healthcare company that competes with BVZ in the development and marketing of pharmaceuticals and diagnostics.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a US-based global pharma company that competes with BVZ in the discovery, development, and manufacture of healthcare products including innovative medicines and vaccines.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that competes with BVZ in providing healthcare solutions and innovations in various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a diversified healthcare giant that competes with BVZ across several segments, including pharmaceuticals, medical devices, and consumer health products.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a British multinational pharmaceutical company that competes with BVZ in pharmaceuticals, vaccines, and consumer healthcare.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a global, research-driven biopharmaceutical company that competes with BVZ in developing and marketing advanced therapies.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focused on human health, competing with BVZ in areas such as pharmaceuticals and vaccines.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with BVZ in the discovery, development, and delivery of innovative medicines.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with BVZ in developing and commercializing prescription medicines across several therapeutic areas.

About

BVZ Holding AG, through its subsidiaries, provides rail-related services. The company offers public railway transport, rolling stock, and maintenance services; tourist services; and automobile and freight transport services. It also engages in management, infrastructure, and real estate business. The company was founded in 1891 and is based in Brig, Switzerland.
Show more...
CEO
ISIN
CH0008207356
WKN
000924111

Listings

F
DE
5K5.F
SW
CH
BVZN.SW
LSE
GB
0QML.LSE

0 Comments

Share your thoughts

FAQ

What is BVZ stock price today?▼
The current price of 5K5.F is €1,620 EUR — it has increased by +1.89% in the past 24 hours. Watch BVZ stock price performance more closely on the chart.
What is BVZ stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BVZ stocks are traded under the ticker 5K5.F.
What is BVZ revenue for the last year?▼
BVZ revenue for the last year amounts to 288.15M EUR.
What is BVZ net income for the last year?▼
5K5.F net income for the last year is 45.75M EUR.
Does BVZ pay dividends?▼
Yes, 5K5.F dividends are paid annual. The last dividend per share was 19.43 EUR. As of today, Dividend Yield (FWD)% is 2.04%.
When did BVZ complete a stock split?▼
BVZ has not had any recent stock splits.